Confo Therapeutics SA

Confo Therapeutics SA discovers and develops therapeutics targeting G protein- coupled receptors for metabolic and endocrine diseases. The company collaborates with pharmaceutical partners and advances small molecule and antibody-based medicines using proprietary technology. It serves patients with metabolic and endocrine conditions in the US and Europe.